Risk of Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer Comment

被引：0
作者：
Kunath, Frank
Wullich, Bernd
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2011年 / 187卷 / 02期
关键词：
MEN;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：144 / 145
页数：2
相关论文
共 4 条
[1]   Intermittent versus continuous androgen suppression for prostatic cancer [J].
Conti, P. D. ;
Atallah, A. N. ;
Arruda, H. ;
Soares, B. G. O. ;
El, Dib R. P. ;
Wilt, T. J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[2]   Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer [J].
Keating, Nancy L. ;
O'Malley, A. James ;
Smith, Matthew R. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4448-4456
[3]   Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study [J].
Khaw, Kay-Tee ;
Dowsett, Mitch ;
Folkerd, Elizabeth ;
Bingham, Sheila ;
Wareham, Nicholas ;
Luben, Robert ;
Welch, Ailsa ;
Day, Nicholas .
CIRCULATION, 2007, 116 (23) :2694-2701
[4]   Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden [J].
Van Hemelrijck, Mieke ;
Garmo, Hans ;
Holmberg, Lars ;
Ingelsson, Erik ;
Bratt, Ola ;
Bill-Axelson, Anna ;
Lambe, Mats ;
Stattin, Par ;
Adolfsson, Jan .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) :3448-3456
1